Zobrazeno 1 - 5
of 5
pro vyhledávání: '"B S, Schnierle"'
Publikováno v:
The British journal of dermatology. 158(3)
The immunomodulator AS101 [ammonium trichloro (dioxoethylene-O,O') tellurate], a nontoxic tellurium (IV) compound, has antitumoral effects which were demonstrated in several preclinical and clinical studies.To investigate the antitumour activity of A
Autor:
B S, Schnierle, B, Groner
Publikováno v:
Gene therapy. 3(12)
The systemic delivery of genes will open new applications for gene therapy. The deployment of retroviral vectors for this purpose is being considered and requires the development of retroviral vectors with a defined target cell specificity of infecti
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 2(6)
We are developing strategies to use naive T lymphocytes in cancer therapy. For this purpose, we are deriving T cells with specificity of recognition for defined tumor cells. To direct effector lymphocytes toward tumor cells, we have manipulated the r
Publikováno v:
Gene therapy. 3(4)
New retroviral constructs with a grafted specificity of infection could become useful gene delivery vehicles with applications in systemic gene therapy. We have constructed retroviral vectors to target gene transfer to human tumor cells. Chimeric env
Publikováno v:
The Journal of biological chemistry. 269(32)
The vaccinia virus-encoded protein VP39 is a poly(A) polymerase subunit that stimulates the formation of long poly(A) tails as well as a cap-specific mRNA (nucleoside-2'-O-)-methyltransferase. We have carried out mutagenesis studies aimed at locating